| Balance sheet (USD) | FY 2025 ended Dec 31, 2025 | FY 2025 ended Dec 31, 2024 | FY 2025 ended Dec 31, 2023 | FY 2022 ended Dec 31, 2022 | FY 2021 ended Dec 31, 2021 | FY 2020 ended Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 9.85B | 4.01B | 8.08B | 8.52B | 4.48B | 10.32B |
| Short-term investments | 253.00M | 1.56B | 3.00M | |||
| Receivables | 8.90B | 8.19B | 8.22B | 8.12B | 7.98B | 5.74B |
| Inventory | 5.42B | 4.98B | 5.09B | 5.63B | 5.05B | 4.03B |
| Total current assets | 28.71B | 22.14B | 24.59B | 25.23B | 20.11B | 21.96B |
| Property, plant and equipment | 10.56B | 9.31B | 9.45B | 9.28B | 8.33B | 5.91B |
| Goodwill and intangibles | 65.20B | 61.39B | 60.69B | 58.64B | 62.04B | 38.73B |
| Total assets | 110.34B | 97.32B | 98.73B | 97.15B | 95.12B | 69.05B |
| Accounts payable | 3.62B | 3.08B | 2.87B | 3.38B | 2.87B | 2.17B |
| Total current liabilities | 15.19B | 13.33B | 14.01B | 17.01B | 13.44B | 10.30B |
| Long-term debt | 35.85B | 29.06B | 31.31B | 28.91B | 32.33B | 19.11B |
| Total liabilities | 56.94B | 47.74B | 51.99B | 53.18B | 54.33B | 34.55B |
| Retained earnings | 59.16B | 53.10B | 47.36B | 41.91B | 35.43B | 28.12B |
| Shareholders' equity | 53.41B | 49.58B | 46.73B | 43.98B | 40.79B | 34.51B |
| Total debt | 39.38B | 31.27B | 34.92B | 34.49B | 34.87B | 21.73B |
| Net debt | 29.53B | 27.27B | 26.84B | 25.96B | 30.39B | 11.41B |
From Thermo Fisher Scientific's 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read balance sheet or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.